# FDA Inspection 1230852 - Byoung Chul Cho, M.D., Ph.D. - February 02, 2024

Source: https://www.keypedia.com/records/fda_inspections/byoung-chul-cho-md-phd/86f88632-a8c8-40ec-8f61-cff7046fe652
Source feed: FDA_Inspections

> FDA Inspection 1230852 for Byoung Chul Cho, M.D., Ph.D. on February 02, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1230852
- Company Name: Byoung Chul Cho, M.D., Ph.D.
- Inspection Date: 2024-02-02
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1172440 - 2022-05-13](https://www.keypedia.com/records/fda_inspections/byoung-chul-cho-md-phd/b60da807-fb1b-416d-8aeb-f8e07c56a141)
- [FDA Inspection 1092851 - 2019-04-26](https://www.keypedia.com/records/fda_inspections/byoung-chul-cho-md-phd/6d80fb00-4ad0-4e59-b635-5143bcd9d519)

Company: https://www.keypedia.com/companies/byoung-chul-cho-md-phd/fc87b816-061b-4330-8688-434a8f313f8d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c